Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.02.2022 | Case report

Empagliflozin

Euglycaemic diabetic ketoacidosis, masking of hyperglycaemia and hyperglycosuria: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Oriot P, et al. Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature. Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine 77: 113-117, No. 1, 2022. Available from: URL: http://doi.org/10.1080/17843286.2020.1780390 Oriot P, et al. Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature. Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine 77: 113-117, No. 1, 2022. Available from: URL: http://​doi.​org/​10.​1080/​17843286.​2020.​1780390
Metadaten
Titel
Empagliflozin
Euglycaemic diabetic ketoacidosis, masking of hyperglycaemia and hyperglycosuria: case report
Publikationsdatum
01.02.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-10608-1

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

COVID-19 vaccine

Case report

AZD-1222